STLV-1 Commonly Targets Neurons in the Brain of Asymptomatic Non-Human Primates

mBio. 2023 Apr 25;14(2):e0352622. doi: 10.1128/mbio.03526-22. Epub 2023 Feb 21.

Abstract

The human T-cell leukemia virus (HTLV)-1 is responsible for an aggressive neurodegenerative disease (HAM/TSP) and multiple neurological alterations. The capacity of HTLV-1 to infect central nervous system (CNS) resident cells, together with the neuroimmune-driven response, has not been well-established. Here, we combined the use of human induced pluripotent stem cells (hiPSC) and of naturally STLV-1-infected nonhuman primates (NHP) as models with which to investigate HTLV-1 neurotropism. Hence, neuronal cells obtained after hiPSC differentiation in neural polycultures were the main cell population infected by HTLV-1. Further, we report the infection of neurons with STLV-1 in spinal cord regions as well as in brain cortical and cerebellar sections of postmortem NHP. Additionally, reactive microglial cells were found in infected areas, suggesting an immune antiviral response. These results emphasize the need to develop new efficient models by which to understand HTLV-1 neuroinfection and suggest an alternative mechanism that leads to HAM/TSP.

Keywords: HTLV-1; inflammation; microglial response; neurotropism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain
  • Human T-lymphotropic virus 1* / physiology
  • Humans
  • Induced Pluripotent Stem Cells*
  • Neurodegenerative Diseases*
  • Neurons
  • Primates
  • Simian T-lymphotropic virus 1*